Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Adjuvant Therapy in Poor Responders Undergoing IVF
NCT02338206Phase 2Completed
- Sponsor
- Woman's Health University Hospital
- Start
- Mar 2015
- Primary completion
- Nov 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised trial of somatropin in infertility (2 arms), sponsored by Woman's Health University Hospital. Primary endpoint: Live birth rate at 12 months. Started Mar 2015; status: completed.
02
Drugs
somatropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02338206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338206.